Multi-centric study identifies genetic variants affecting treatment response in multiple sclerosis, highlighting research challenges.
This study identified novel genetic variants for GA response, implicating genes in crucial pathways. For IFN-β, suggestive signals point to immune and interferon-related genes. These findings enhance our understanding of genetic influences on RRMS treatment response, while highlighting pharmacogenomic research challenges.
No takes yet. Share an insight, caveat, or question.
Corona et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: